Leadership

Neil A. Goldenberg, MD, PhD

neil-goldenberg

Associate Professor of Pediatrics

Dr. Neil Goldenberg is an associate professor of pediatrics at the Johns Hopkins University School of Medicine. He also is director of research at Johns Hopkins All Children’s Hospital, chief research officer of the Johns Hopkins All Children’s Hospital Research Institute, and director of the Clinical and Translational Research Organization at Johns Hopkins All Children’s Hospital. His research focuses on pediatric thrombosis and he is director of the pediatric thrombosis program at Johns Hopkins All Children’s Hospital and is co-director of the pediatric stroke program. He also leads the Prospective Multicenter Evaluation of the Duration of Therapy for Thrombosis in Children (known as KIDS-DOTT), a study that involves more than two dozen medical institutions.

After receiving his medical degree from McGill University Faculty of Medicine in Montréal, Dr. Goldenberg completed his internship and residency at the University of South Florida College of Medicine as a member of the inaugural class of the combined residency program in internal medicine and pediatrics. He performed a fellowship in pediatric hematology/oncology/bone marrow transplant at The Children’s Hospital, Denver (now Children’s Hospital Colorado), and the University of Colorado Health Sciences Center, where he also earned a Ph.D. in clinical investigation.

After receiving his medical degree from McGill University Faculty of Medicine in Montréal, Dr. Goldenberg completed his internship and residency at the University of South Florida College of Medicine as a member of the inaugural class of the combined residency program in internal medicine and pediatrics. He performed a fellowship in pediatric hematology/oncology/bone marrow transplant at The Children’s Hospital, Denver (now Children’s Hospital Colorado), and the University of Colorado Health Sciences Center, where he also earned a Ph.D. in clinical investigation.

Prior to joining Johns Hopkins in 2012, Dr. Goldenberg was on the faculty of the University of Colorado School of Medicine and served as director of the Children’s Clinical Research Organization and co-director of the Pediatric Thrombosis and Stroke Programs at Children’s Hospital Colorado. He also served as director of the Department of Clinical Science and Safety at CPC Clinical Research, a non-profit clinical trials management organization affiliated with the University of Colorado, after having served as director of Clinical Research for the Mountain States Regional Hemophilia and Thrombosis Center.

Dr. Goldenberg received a five-year Career Development Award from the National Institutes of Health/National Heart, Lung and Blood Institute and also received the Eberhard E. Mammen Award for Excellence in Hemostasis and Thrombosis in 2012. He has held additional research grants from the American Society of Hematology (ASH), the Hemophilia and Thrombosis Research Society and the National Hemophilia Foundation. Dr. Goldenberg is the Principal Investigator, Steering Committee Chair, or Data and Safety Monitoring Committee chair for NIH- and industry-sponsored multicenter clinical trials, and has co-authored international clinical and clinical research guidelines.

He was a member of the American Heart Association’s Writing Committee on Venous Thromboembolic Disease and a pediatric representative to the Surgeon General’s Workshops on Deep Vein Thrombosis Surveillance (co-sponsored by the Centers for Disease Control). He serves on the editorial board of Thrombosis Research, has been a reviewer for Lancet, Lancet Oncology, Pediatrics, Blood, and other journals, and speaks nationally on coagulation disorders, stroke, and clinical research methods.

Publications

Multicenter randomized controlled trial on Duration of Therapy for Thrombosis in Children and Young Adults (the Kids-DOTT trial): pilot/feasibility phase findings.


Goldenberg NA, Abshire T, Blatchford PJ, Fenton LZ, Halperin JL, Hiatt WR, Kessler CM, Kittelson JM, Manco-Johnson MJ, Spyropoulos AC, Steg PG, Stence NV, Turpie AG, Schulman S; Kids-DOTT Trial Investigators.

The postthrombotic syndrome: evidence-based prevention, diagnosis, and treatment strategies: a scientific statement from the American Heart Association.


Kahn SR, Comerota AJ, Cushman M, Evans NS, Ginsberg JS, Goldenberg NA, Gupta DK, Prandoni P, Vedantham S, Walsh ME, Weitz JI; American Heart Association Council on Peripheral Vascular Disease, Council on Clinical Cardiology, and Council on Cardiovascular and Stroke Nursing.

The postthrombotic syndrome: evidence-based prevention, diagnosis, and treatment strategies: a scientific statement from the American Heart Association.


Kahn SR, Comerota AJ, Cushman M, Evans NS, Ginsberg JS, Goldenberg NA, Gupta DK, Prandoni P, Vedantham S, Walsh ME, Weitz JI; American Heart Association Council on Peripheral Vascular Disease, Council on Clinical Cardiology, and Council on Cardiovascular and Stroke Nursing.

Elevated plasma factor VIII and D-dimer levels as predictors of poor outcomes of thrombosis in children.


Goldenberg NA, Knapp-Clevenger R, Manco-Johnson MJ; Mountain States Regional Thrombophilia Group.

For additional research publications please visit: https://www.researchgate.net/profile/Neil_Goldenberg